University of Washington

University / College


Location: Seattle, WA, United States (USA) (US) US

ISNI: 0000000122986657

ROR: https://ror.org/00cvxb145

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fermi-LAT Observations of LIGO/Virgo Event GW170817 (2018) Ajello M, Allafort A, Axelsson M, Baldini L, Barbiellini G, Baring MG, Bastieri D, et al. Journal article Evidence for a shared genetic basis between breast cancer and mammographic density phenotypes (2018) Chen H, Douglas J, Gordon W, Thompson D, Couch F, Fasching P, Hall P, et al. Conference contribution International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Investigating source confusion in PMN J1603-4904 (2018) Krauss F, Kreter M, Mueller C, Markowitz A, Böck M, Burnett T, Dauser T, et al. Journal article Einstein@Home discovers a radio-quiet gamma-ray millisecond pulsar (2018) Clark CJ, Pletsch HJ, Wu J, Guillemot L, Kerr M, Johnson TJ, Camilo F, et al. Journal article Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. (2018) Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, et al. Journal article The Immune Landscape of Cancer. (2018) Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang THO, Porta-Pardo E, et al. Journal article Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study (2018) Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, Kremer A, et al. Conference contribution ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution Characterization of Glomerular Sox9+ Cells in Anti-Glomerular Basement Membrane Nephritis in the Rat (2018) Prochnicki A, Amann KU, Wegner M, Sock E, Pfister E, Shankland S, Pippin J, Daniel C Journal article